|
US3870790A
(en)
*
|
1970-01-22 |
1975-03-11 |
Forest Laboratories |
Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
|
|
GB1472534A
(en)
*
|
1973-07-06 |
1977-05-04 |
Glaxo Lab Ltd |
7beta-hydroxyiminoacylamido-cephalosporins
|
|
JPS5119765A
(en)
*
|
1974-08-09 |
1976-02-17 |
Takeda Chemical Industries Ltd |
Aminochiazoorujudotaino seizoho |
|
US6218380B1
(en)
*
|
1975-04-17 |
2001-04-17 |
Smithkline Beecham P.L.C. |
Pharmaceutical compositions
|
|
US6031093C1
(en)
*
|
1975-04-17 |
2001-10-16 |
Smithkline Beecham Plc |
Solid salts of clavulanic acid
|
|
US4018918A
(en)
*
|
1975-05-20 |
1977-04-19 |
The Upjohn Company |
Topical clindamycin preparations
|
|
US4250166A
(en)
*
|
1977-05-27 |
1981-02-10 |
Shionogi & Co., Ltd. |
Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
|
|
US4369172A
(en)
*
|
1981-12-18 |
1983-01-18 |
Forest Laboratories Inc. |
Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
|
|
US4435173A
(en)
*
|
1982-03-05 |
1984-03-06 |
Delta Medical Industries |
Variable rate syringe pump for insulin delivery
|
|
US4430495A
(en)
*
|
1982-09-17 |
1984-02-07 |
The Upjohn Company |
Process for preparing lincomycin and clindamycin ribonucleotides
|
|
AU575854B2
(en)
*
|
1983-10-04 |
1988-08-11 |
Shionogi & Co., Ltd. |
7beta-(carboxyalkenamido) cephalosporins
|
|
DE3405378A1
(de)
*
|
1984-02-15 |
1985-08-22 |
Röhm GmbH, 6100 Darmstadt |
Arzneimittelueberzug
|
|
US4568741A
(en)
*
|
1984-05-15 |
1986-02-04 |
The Upjohn Company |
Synthesis of 7-halo-7-deoxylincomycins
|
|
US4894119A
(en)
*
|
1985-04-10 |
1990-01-16 |
Drew Chemical Corporation |
Retention and/or drainage and/or dewatering aid
|
|
US4728512A
(en)
*
|
1985-05-06 |
1988-03-01 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
EP0230654B1
(en)
*
|
1985-12-28 |
1992-03-18 |
Sumitomo Pharmaceuticals Company, Limited |
Sustained pulsewise release pharmaceutical preparation
|
|
US4904476A
(en)
*
|
1986-03-04 |
1990-02-27 |
American Home Products Corporation |
Formulations providing three distinct releases
|
|
US4723958A
(en)
*
|
1986-05-23 |
1988-02-09 |
Merck & Co., Inc. |
Pulsatile drug delivery system
|
|
NZ220764A
(en)
*
|
1986-07-02 |
1989-09-27 |
Shionogi & Co |
Crystalline form of 7beta((z)-2-(2-aminothiazol-4-yl)-4- carboxybut-2-enoylamino)-3-cephem-4-carboxylic acid and pharmaceutical compositions
|
|
KR960000434B1
(ko)
*
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
US4808411A
(en)
*
|
1987-06-05 |
1989-02-28 |
Abbott Laboratories |
Antibiotic-polymer compositions
|
|
US4915953A
(en)
*
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering acetaminophen or phenylpropanolamine
|
|
US4895934A
(en)
*
|
1988-08-22 |
1990-01-23 |
E. I. Du Pont De Nemours And Company |
Process for the preparation of clindamycin phosphate
|
|
US5178874A
(en)
*
|
1989-06-30 |
1993-01-12 |
Smithkline Beechman Corporation |
Intermittent release dosage form
|
|
US5204055A
(en)
*
|
1989-12-08 |
1993-04-20 |
Massachusetts Institute Of Technology |
Three-dimensional printing techniques
|
|
US5387380A
(en)
*
|
1989-12-08 |
1995-02-07 |
Massachusetts Institute Of Technology |
Three-dimensional printing techniques
|
|
JPH0674206B2
(ja)
*
|
1989-12-28 |
1994-09-21 |
田辺製薬株式会社 |
放出制御型製剤およびその製法
|
|
US5182374A
(en)
*
|
1990-03-21 |
1993-01-26 |
American Cyanamid Company |
Clindamycin phosphate synthesis
|
|
GB2253346A
(en)
*
|
1991-02-22 |
1992-09-09 |
John Rhodes |
Delayed release oral dosage forms for treatment of intestinal disorders
|
|
GB9109862D0
(en)
*
|
1991-05-08 |
1991-07-03 |
Beecham Lab Sa |
Pharmaceutical formulations
|
|
US5260066A
(en)
*
|
1992-01-16 |
1993-11-09 |
Srchem Incorporated |
Cryogel bandage containing therapeutic agent
|
|
TW203552B
(en)
*
|
1992-02-18 |
1993-04-11 |
J Baroody Lloyd |
Compositions of clindamycin and benzoyl peroxide for acne treatment
|
|
JP3265680B2
(ja)
*
|
1992-03-12 |
2002-03-11 |
大正製薬株式会社 |
経口製剤用組成物
|
|
RU2123863C1
(ru)
*
|
1992-04-30 |
1998-12-27 |
Шеринг Корпорейшн |
Содержащая гидратированный цефтибутен порошковая антибактериальная композиция, предназначенная для орального использования в виде суспензии
|
|
US5260068A
(en)
*
|
1992-05-04 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Multiparticulate pulsatile drug delivery system
|
|
MX9304638A
(es)
*
|
1992-07-31 |
1994-05-31 |
Neose Pharm Inc |
Composicion para tratar e inhibir las ulceras gastricas y duodenales.
|
|
US5260069A
(en)
*
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
US6183778B1
(en)
*
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
|
US5490962A
(en)
*
|
1993-10-18 |
1996-02-13 |
Massachusetts Institute Of Technology |
Preparation of medical devices by solid free-form fabrication methods
|
|
US6280771B1
(en)
*
|
1997-02-20 |
2001-08-28 |
Therics, Inc. |
Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof
|
|
US5393765A
(en)
*
|
1993-12-13 |
1995-02-28 |
Hoffmann-La Roche Inc. |
Pharmaceutical compositions with constant erosion volume for zero order controlled release
|
|
DE4404018A1
(de)
*
|
1994-02-09 |
1995-08-10 |
Merck Patent Gmbh |
Protrahiert freisetzende Darreichungsformen enthaltend Clindamycin-Palmitat
|
|
US5395626A
(en)
*
|
1994-03-23 |
1995-03-07 |
Ortho Pharmaceutical Corporation |
Multilayered controlled release pharmaceutical dosage form
|
|
GB9407386D0
(en)
*
|
1994-04-14 |
1994-06-08 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
GB9408117D0
(en)
*
|
1994-04-23 |
1994-06-15 |
Smithkline Beecham Corp |
Pharmaceutical formulations
|
|
GB9416599D0
(en)
*
|
1994-08-17 |
1994-10-12 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
GB9416600D0
(en)
*
|
1994-08-17 |
1994-10-12 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
US5872104A
(en)
*
|
1994-12-27 |
1999-02-16 |
Oridigm Corporation |
Combinations and methods for reducing antimicrobial resistance
|
|
US6548084B2
(en)
*
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
|
US5872229A
(en)
*
|
1995-11-21 |
1999-02-16 |
Abbott Laboratories |
Process for 6-O-alkylation of erythromycin derivatives
|
|
US5705190A
(en)
*
|
1995-12-19 |
1998-01-06 |
Abbott Laboratories |
Controlled release formulation for poorly soluble basic drugs
|
|
US5766220A
(en)
*
|
1996-02-29 |
1998-06-16 |
Moenning; Stephen P. |
Apparatus and method for protecting a port site opening in the wall of a body cavity
|
|
US5719272A
(en)
*
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
US5719132A
(en)
*
|
1996-06-27 |
1998-02-17 |
Bristol-Myers Squibb Company |
Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
|
|
US5858986A
(en)
*
|
1996-07-29 |
1999-01-12 |
Abbott Laboratories |
Crystal form I of clarithromycin
|
|
GB9617780D0
(en)
*
|
1996-08-24 |
1996-10-02 |
Smithkline Beecham Plc |
Method of treatment
|
|
IL119627A
(en)
*
|
1996-11-17 |
2002-03-10 |
Yissum Res Dev Co |
PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
|
|
IT1289160B1
(it)
*
|
1997-01-08 |
1998-09-29 |
Jagotec Ag |
Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di
|
|
US5864023A
(en)
*
|
1997-02-13 |
1999-01-26 |
Abbott Laboratories |
3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
|
|
US6010718A
(en)
*
|
1997-04-11 |
2000-01-04 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US20050064033A1
(en)
*
|
1997-04-11 |
2005-03-24 |
Notario Gerard F. |
Extended release formulations of erythromycin derivatives
|
|
US6551616B1
(en)
*
|
1997-04-11 |
2003-04-22 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US6210710B1
(en)
*
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
|
US5877243A
(en)
*
|
1997-05-05 |
1999-03-02 |
Icet, Inc. |
Encrustation and bacterial resistant coatings for medical applications
|
|
US5840329A
(en)
*
|
1997-05-15 |
1998-11-24 |
Bioadvances Llc |
Pulsatile drug delivery system
|
|
ATE302597T1
(de)
*
|
1997-06-06 |
2005-09-15 |
Depomed Inc |
Im magen verweilende orale dosierungsformen von wasserlöslichen arzneistoffen mit kontrollierter freisetzung
|
|
KR100377159B1
(ko)
*
|
1998-09-09 |
2003-08-19 |
한미약품공업 주식회사 |
잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
|
|
US6477410B1
(en)
*
|
2000-05-31 |
2002-11-05 |
Biophoretic Therapeutic Systems, Llc |
Electrokinetic delivery of medicaments
|
|
DE19938704C1
(de)
*
|
1999-08-14 |
2001-10-31 |
Ivoclar Vivadent Ag |
Verfahren zur Herstellung von Reaktionssystemen zur Implantation in den menschlichen und tierischen Körper als Knochenersatz, die u.a. Calcium und Phosphor enthalten
|
|
US6515010B1
(en)
*
|
1999-11-15 |
2003-02-04 |
Smithkline Beecham Corporation |
Carvedilol methanesulfonate
|
|
HRP20020522A2
(en)
*
|
1999-12-16 |
2004-12-31 |
Teva Pharma |
Processes for preparing clarithromycin polymorphs and novel polymorph iv
|
|
PL356645A1
(en)
*
|
2000-01-11 |
2004-06-28 |
Teva Pharmaceutical Industries Ltd. |
Processes for preparing clarithromycin polymorphs
|
|
CA2395974A1
(en)
*
|
2000-01-20 |
2001-07-26 |
Suggy S. Chrai |
Multi-step drug dosage forms
|
|
EP1257255A4
(en)
*
|
2000-02-24 |
2008-07-30 |
Advancis Pharmaceutical Corp |
THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
|
|
US6730320B2
(en)
*
|
2000-02-24 |
2004-05-04 |
Advancis Pharmaceutical Corp. |
Tetracycline antibiotic product, use and formulation thereof
|
|
US6544555B2
(en)
*
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US6610328B2
(en)
*
|
2000-02-24 |
2003-08-26 |
Advancis Pharmaceutical Corp. |
Amoxicillin-clarithromycin antibiotic composition
|
|
US6667057B2
(en)
*
|
2000-02-24 |
2003-12-23 |
Advancis Pharmaceutical Corp. |
Levofloxacin antibiotic product, use and formulation thereof
|
|
US6663890B2
(en)
*
|
2000-02-24 |
2003-12-16 |
Advancis Pharmaceutical Corp. |
Metronidazole antibiotic product, use and formulation thereof
|
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
|
US20020004070A1
(en)
*
|
2000-02-24 |
2002-01-10 |
Rudnic Edward M. |
Antineoplastic product, use and formulation thereof
|
|
AU3984101A
(en)
*
|
2000-02-24 |
2001-09-03 |
Advanced Pharma Inc |
Antibiotic and antifungal compositions
|
|
EP1292381B1
(en)
*
|
2000-05-03 |
2009-07-15 |
D'SILVA, Joe |
Process and device for producing liquid dosage formulations
|
|
CA2408956C
(en)
*
|
2000-05-18 |
2011-07-12 |
Therics, Inc. |
Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form
|
|
WO2001092288A2
(en)
*
|
2000-05-31 |
2001-12-06 |
Mayo Foundation For Medical Education And Research |
Cobalamin compounds useful as antibiotic agents and as imaging agents
|
|
US6696426B2
(en)
*
|
2000-08-22 |
2004-02-24 |
Pharmacia Corporation |
Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
|
|
AU2001291526A1
(en)
*
|
2000-09-22 |
2002-04-02 |
Galephar M/F |
Sustained release composition containing clarithromycin
|
|
US6541014B2
(en)
*
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
|
GB0102342D0
(en)
*
|
2001-01-30 |
2001-03-14 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
|
CN1543337A
(zh)
*
|
2001-08-16 |
2004-11-03 |
���ո����ɸߵȽ�����ίԱ�������� |
可膨胀的胃潴留装置
|
|
US20030073648A1
(en)
*
|
2001-08-28 |
2003-04-17 |
Chao Robert S. |
Crystaline clindamycin free base
|
|
WO2003017981A1
(en)
*
|
2001-08-29 |
2003-03-06 |
Ranbaxy Laboratories Limited |
Controlled release formulation of clarithromycin or tinidazol
|
|
US9358214B2
(en)
*
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
|
CA2409552A1
(en)
*
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
WO2003105810A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
|
US20040033262A1
(en)
*
|
2002-08-19 |
2004-02-19 |
Orchid Health Care |
Sustained release pharmaceutical composition of a cephalosporin antibiotic
|
|
EP1638529B1
(en)
*
|
2003-06-16 |
2016-08-10 |
ANDRX Pharmaceuticals, LLC. |
Oral extended-release composition
|
|
US20050053658A1
(en)
*
|
2003-09-09 |
2005-03-10 |
Venkatesh Gopi M. |
Extended release systems for macrolide antibiotics
|